Emcure Pharmaceuticals (NSE:EMCURE) OCF Margin %: 0.00% (As of Mar. 2026)


NSE:EMCURE Emcure Pharmaceuticals Ltd NSE:EMCURE
41 GF Score
Price ₹1,849.50
! 5 Warning Signs
View Full Analysis

What is Emcure Pharmaceuticals OCF Margin %?

Emcure Pharmaceuticals NSE:EMCURE -1.63% 41 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 956 Drug Manufacturers companies, Emcure Pharmaceuticals ranks better than 51.46% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Emcure Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was ₹0 Mil. Emcure Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was ₹24,697 Mil. Therefore, Emcure Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Emcure Pharmaceuticals's current OCF Yield % is 2.64%.

The historical rank and industry rank for Emcure Pharmaceuticals's OCF Margin % or its related term are showing as below:

NSE:EMCURE' s OCF Margin % Range Over the Past 10 Years
Min: 10.25   Med: 12.96   Max: 16.67
Current: 10.25

During the past 6 years, the highest OCF Margin % of Emcure Pharmaceuticals was 16.67%. The lowest was 10.25%. And the median was 12.96%.

NSE:EMCURE's OCF Margin % is ranked better than
51.46% of 956 companies
in the Drug Manufacturers industry
Industry Median: 9.985 vs NSE:EMCURE: 10.25

Emcure Pharmaceuticals OCF Margin % Related Terms

Emcure Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Emcure Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emcure Pharmaceuticals OCF Margin % Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial 13.32 12.59 16.67 10.79 10.25

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:EMCURE vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emcure Pharmaceuticals OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Emcure Pharmaceuticals's OCF Margin % falls into.


NSE:EMCURE
41GF Score
Emcure Pharmaceuticals Ltd NSE:EMCURE
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emcure Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Emcure Pharmaceuticals's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=9435.45/92035.4
=10.25 %

Emcure Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/24697.03
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Emcure Pharmaceuticals (NSE:EMCURE) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Emcure Pharmaceuticals and its competitors. Over the past decade, Emcure Pharmaceuticals' OCF Margin % has ranged from 10.25 to 16.67. According to the industry distribution chart, Emcure Pharmaceuticals ranks #464 out of 956 companies in the Drug Manufacturers industry, placing it in the top 48.5%.
Is Emcure Pharmaceuticals' OCF Margin % too high?
Emcure Pharmaceuticals' current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 10.25 to a high of 16.67. Based on the distribution chart, Emcure Pharmaceuticals ranks #464 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Emcure Pharmaceuticals has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Emcure Pharmaceuticals ranks #464 out of 956 companies for OCF Margin %. This puts Emcure Pharmaceuticals in the upper half of its industry. The industry median OCF Margin % is 9.99. Historically, Emcure Pharmaceuticals' own OCF Margin % has ranged from 10.25 to 16.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Emcure Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emcure Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Emcure Pharmaceuticals' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emcure Pharmaceuticals Business Description

Other Exchanges 544210:India
Address Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune, MH, IND, 411 057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
41GF Score

Get the complete analysis for NSE:EMCURE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,849.50
Price